Spontaneous regression of breast cancer with axillary lymph node metastasis: A case report and review of literature

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 4371-4380

  Tokunaga, Eriko ^a   Okano, Shinji ^a   Nakashima, Yuichiro ^a   Yamashita, Nami ^a   Tanaka, Kimihiro ^a   Akiyoshi, Sauri ^a   Taketani, Kenji ^a   Shirouzu, Mitsunori ^b   Yamamoto, Hidetaka ^a   Morita, Masaru ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Shirouzu Breast Surgery Clinic   (Japan)

Author keywords

Breast cancer; Cancer immunology; Spontaneous regression; T cell response

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

BREAST TUMOR; CASE REPORT; COMPLICATION; DIABETES MELLITUS, TYPE 2; FEMALE; HUMAN; IMMUNOLOGY; LYMPH NODE METASTASIS; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR REGRESSION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; NEOPLASM REGRESSION, SPONTANEOUS; T-LYMPHOCYTES;

EID: 84906238771     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cole WH. Spontaneous regression of cancer and the importance of finding its cause. Natl Cancer Inst Monogr 1976; 44: 5-9.
2. Cole WH. Efforts to explain spontaneous regression of cancer. J Surg Oncol 1981; 17: 201-9.
3. Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot HC, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012; 366: 2455-65.
4. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, Leming PD, Spigel DR, Antonia SJ, Horn L, Drake CG, Pardoll DM, Chen L, Sharfman WH, Anders RA, Taube JM, McMiller TL, Xu H, Korman AJ, Jure-Kunkel M, Agrawal S, McDonald D, Kollia GD, Gupta A, Wigginton JM, Sznol M. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366: 2443-54.
5. Abdelrazeq AS. Spontaneous regression of colorectal cancer: a review of cases from 1900 to 2005. Int J Colorectal Dis 2007; 22: 727-36.
6. Challis GB, Stam HJ. The spontaneous regression of cancer. A review of cases from 1900 to 1987. Acta oncologica 1990; 29: 545-50.
7. Dussan C, Zubor P, Fernandez M, Yabar A, Szunyogh N, Visnovsky J. Spontaneous regression of a breast carcinoma: a case report. Gynecol Obstet Invest 2008; 65: 206-11.
8. Maiche AG, Jekunen A, Rissanen P, Virkkunen P, Halavaara J, Turunen JP. Sudden tumour regression with enhanced natural killer cell accumulation in a patient with stage IV breast cancer. Eur J Cancer 1994; 30A: 1642-6.
9. Iwatani T, Kawabata H, Miura D, Ota Y, Ohashi K. Complete spontaneous regression of primary diffuse large B-cell lymphoma of the breast. J Clin Oncol 2011; 29: e113-5.
10. Oya M, Hirahashi M, Ochi M, Hashimoto M, Ohshima K, Kikuchi M, Tsuneyoshi M. Spontaneous regression of primary breast lymphoma. Pathol Int 2009; 59: 664-9.
11. Iihara K, Yamaguchi K, Nishimura Y, Iwasaki T, Suzuki K, Hirabayashi Y. Spontaneous regression of malignant lymphoma of the breast. Pathol Int 2004; 54: 537-42.
12. Stoll BA. Spontaneous regression of cancer: new insights. Biotherapy 1992; 4: 23-30.
13. Papac RJ. Spontaneous regression of cancer. Cancer Treat Rev 1996; 22: 395-423.
14. Nagayama H, Sato K, Morishita M, Uchimaru K, Oyaizu N, Inazawa T, Yamasaki T, Enomoto M, Nakaoka T, Nakamura T, Maekawa T, Yamamoto A, Shimada S, Saida T, Kawakami Y, Asano S, Tani K, Takahashi TA, Yamashita N. Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2. Melanoma Res 2003; 13: 521-30.
15. Tani K, Azuma M, Nakazaki Y, Oyaizu N, Hase H, Ohata J, Takahashi K, OiwaMonna M, Hanazawa K, Wakumoto Y, Kawai K, Noguchi M, Soda Y, Kunisaki R, Watari K, Takahashi S, Machida U, Satoh N, Tojo A, Maekawa T, Eriguchi M, Tomikawa S, Tahara H, Inoue Y, Yoshikawa H, Yamada Y, Iwamoto A, Hamada H, Yamashita N, Okumura K, Kakizoe T, Akaza H, Fujime M, Clift S, Ando D, Mulligan R, Asano S. Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings. Mol Ther 2004; 10: 799-816.
16. Hahn S, Gehri R, Erb P. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol Rev 1995; 146: 57-79.
17. Zahl PH, Andersen JM, Maehlen J. Spontaneous regression of cancerous tumors detected by mammography screening. JAMA 2004; 292: 2579-80; author reply 80.